Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1993;2(3):181–198. doi: 10.1155/S0962935193000250

Hormonal control of inflammatory responses

J Garcia-Leme 1,✉, Sandra P Farsky 1
PMCID: PMC2365405  PMID: 18475521

Abstract

Almost any stage of inflammatory and immunological responses is affected by hormone actions. This provides the basis for the suggestion that hormones act as modulators of the host reaction against trauma and infection. Specific hormone receptors are detected in the reactive structures in inflamed areas and binding of hormone molecules to such receptors results in the generation of signals that influence cell functions relevant for the development of inflammatory responses. Diversity of hormonal functions accounts for recognized pro- and anti-inflammatory effects exerted by these substances. Most hormone systems are capable of influencing inflammatory events. Insulin and glucocorticoids, however, exert direct regulatory effects at concentrations usually found in plasma. Insulin is endowed with facilitatory actions on vascular reactivity to inflammatory mediators and inflammatory cell functions. Increased concentrations of circulating glucocorticoids at the early stages of inflammation results in downregulation of inflammatory responses. Oestrogens markedly reduce the response to injury in a variety of experimental models. Glucagon and thyroid hormones exert indirect anti-inflammatory effects mediated by the activity of the adrenal cortex. Accordingly, inflammation is not only merely a local response, but a hormone-controlled process.

Full Text

The Full Text of this article is available as a PDF (2.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albelda S. M., Buck C. A. Integrins and other cell adhesion molecules. FASEB J. 1990 Aug;4(11):2868–2880. [PubMed] [Google Scholar]
  2. Anderson D. C., Springer T. A. Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins. Annu Rev Med. 1987;38:175–194. doi: 10.1146/annurev.me.38.020187.001135. [DOI] [PubMed] [Google Scholar]
  3. Andreani D., Menzinger G., Fallucca F., Aliberti G., Tamburrano G., Cassano C. Insulin levels in thyrotoxicosis and primary myxoedema: response to intravenous glucose and glucagon. Diabetologia. 1970 Feb;6(1):1–7. doi: 10.1007/BF00425884. [DOI] [PubMed] [Google Scholar]
  4. Arnaout M. A. Leukocyte adhesion molecules deficiency: its structural basis, pathophysiology and implications for modulating the inflammatory response. Immunol Rev. 1990 Apr;114:145–180. doi: 10.1111/j.1600-065x.1990.tb00564.x. [DOI] [PubMed] [Google Scholar]
  5. Asano T., Okumura M. Insulin delivery rate in response to glucose and arginine infusion in hyperthyroidism. Diabetologia. 1982 Aug;23(2):108–113. doi: 10.1007/BF01271170. [DOI] [PubMed] [Google Scholar]
  6. Atherton A., Born G. V. Quantitative investigations of the adhesiveness of circulating polymorphonuclear leucocytes to blood vessel walls. J Physiol. 1972 Apr;222(2):447–474. doi: 10.1113/jphysiol.1972.sp009808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. BONTA I. L., DE VOS C. J., DELVER A. INHIBITORY EFFECTS OF ESTRIOL-16,17-DISODIUM SUCCINATE ON LOCAL HAEMORRHAGES INDUCED BY SNAKE VENOM IN CANINE HEART-LUNG PREPARATIONS. Acta Endocrinol (Copenh) 1965 Jan;48:137–146. doi: 10.1530/acta.0.0480137. [DOI] [PubMed] [Google Scholar]
  8. BONTA I. L., DE VOS C. J. THE EFFECT OF ESTRIOL-16,17-DIHEMISUCCINATE ON VASCULAR PERMEABILITY AS EVALUATED IN THE RAT PAW OEDEMA TEST. Acta Endocrinol (Copenh) 1965 Jul;49:403–411. doi: 10.1530/acta.0.0490403. [DOI] [PubMed] [Google Scholar]
  9. Bagdade J. D. Phagocytic and microbicidal function in diabetes mellitus. Acta Endocrinol Suppl (Copenh) 1976;205:27–34. [PubMed] [Google Scholar]
  10. Balow J. E., Rosenthal A. S. Glucocorticoid suppression of macrophage migration inhibitory factor. J Exp Med. 1973 Apr 1;137(4):1031–1041. doi: 10.1084/jem.137.4.1031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bar R. S., Hoak J. C., Peacock M. L. Insulin receptors in human endothelial cells: identification and characterization. J Clin Endocrinol Metab. 1978 Sep;47(3):699–702. doi: 10.1210/jcem-47-3-699. [DOI] [PubMed] [Google Scholar]
  12. Bar R. S., Kahn C. R., Koren H. S. Insulin inhibition of antibody-dependent cytoxicity and insulin receptors in macrophages. Nature. 1977 Feb 17;265(5595):632–635. doi: 10.1038/265632a0. [DOI] [PubMed] [Google Scholar]
  13. Bar R. S., Peacock M. L., Spanheimer R. G., Veenstra R., Hoak J. C. Differential binding of insulin to human arterial and venous endothelial cells in primary culture. Diabetes. 1980 Dec;29(12):991–995. doi: 10.2337/diab.29.12.991. [DOI] [PubMed] [Google Scholar]
  14. Bateman A., Singh A., Kral T., Solomon S. The immune-hypothalamic-pituitary-adrenal axis. Endocr Rev. 1989 Feb;10(1):92–112. doi: 10.1210/edrv-10-1-92. [DOI] [PubMed] [Google Scholar]
  15. Baxter J. D. Glucocorticoid hormone action. Pharmacol Ther B. 1976;2(3):605–669. doi: 10.1016/0306-039x(76)90010-6. [DOI] [PubMed] [Google Scholar]
  16. Baxter J. D. Minimizing the side effects of glucocorticoid therapy. Adv Intern Med. 1990;35:173–193. [PubMed] [Google Scholar]
  17. Beisel W. R. Metabolic response to infection. Annu Rev Med. 1975;26:9–20. doi: 10.1146/annurev.me.26.020175.000301. [DOI] [PubMed] [Google Scholar]
  18. Bertagna X., Bertagna C., Luton J. P., Husson J. M., Girard F. The new steroid analog RU 486 inhibits glucocorticoid action in man. J Clin Endocrinol Metab. 1984 Jul;59(1):25–28. doi: 10.1210/jcem-59-1-25. [DOI] [PubMed] [Google Scholar]
  19. Besedovsky H., del Rey A., Sorkin E., Dinarello C. A. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science. 1986 Aug 8;233(4764):652–654. doi: 10.1126/science.3014662. [DOI] [PubMed] [Google Scholar]
  20. Beutler B., Cerami A. Cachectin: more than a tumor necrosis factor. N Engl J Med. 1987 Feb 12;316(7):379–385. doi: 10.1056/NEJM198702123160705. [DOI] [PubMed] [Google Scholar]
  21. Bevilacqua M. P., Pober J. S., Wheeler M. E., Cotran R. S., Gimbrone M. A., Jr Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest. 1985 Nov;76(5):2003–2011. doi: 10.1172/JCI112200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Björk J., Goldschmidt T., Smedegård G., Arfors K. E. Methylprednisolone acts at the endothelial cell level reducing inflammatory responses. Acta Physiol Scand. 1985 Feb;123(2):221–224. doi: 10.1111/j.1748-1716.1985.tb07581.x. [DOI] [PubMed] [Google Scholar]
  23. Blecher M., Goldstein S. Hormone receptors: VI. On the nature of the binding of glucagon and insulin to human circulating mononuclear leukocytes. Mol Cell Endocrinol. 1977 Oct;8(4):301–315. doi: 10.1016/0303-7207(77)90005-3. [DOI] [PubMed] [Google Scholar]
  24. Bochner B. S., Rutledge B. K., Schleimer R. P. Interleukin 1 production by human lung tissue. II. Inhibition by anti-inflammatory steroids. J Immunol. 1987 Oct 1;139(7):2303–2307. [PubMed] [Google Scholar]
  25. Bodel P., Dillard G. M., Jr, Kaplan S. S., Malawista S. E. Anti-inflammatory effects of estradiol on human blood leukocytes. J Lab Clin Med. 1972 Sep;80(3):373–384. [PubMed] [Google Scholar]
  26. Bonta I. L., Vargaftig B. B., de Vos C. J., Grijsen H. Haemorrhagic mechanisms of some snake venoms in relation to protection by estriol succinate of blood vessel damage. Life Sci. 1969 Aug 1;8(15):881–888. doi: 10.1016/0024-3205(69)90145-3. [DOI] [PubMed] [Google Scholar]
  27. Bucala R., Cerami A. Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. Adv Pharmacol. 1992;23:1–34. doi: 10.1016/s1054-3589(08)60961-8. [DOI] [PubMed] [Google Scholar]
  28. Buschard K., Madsbad S., Rygaard J. Depressed suppressor cell activity in patients with newly diagnosed insulin-dependent diabetes mellitus. Clin Exp Immunol. 1980 Jul;41(1):25–32. [PMC free article] [PubMed] [Google Scholar]
  29. Butler W. T. Corticosteroids and immunoglobulin synthesis. Transplant Proc. 1975 Mar;7(1):49–53. [PubMed] [Google Scholar]
  30. Casley-Smith J. R., Window J. Quantitative morphological correlations of alterations in capillary permeability, following histamine and moderate burning, in the mouse diaphragm; and the effects of benzopyrones. Microvasc Res. 1976 May;11(3):279–305. doi: 10.1016/0026-2862(76)90059-5. [DOI] [PubMed] [Google Scholar]
  31. Claman H. N. Corticosteroids and lymphoid cells. N Engl J Med. 1972 Aug 24;287(8):388–397. doi: 10.1056/NEJM197208242870806. [DOI] [PubMed] [Google Scholar]
  32. Claman H. N. How corticosteroids work. J Allergy Clin Immunol. 1975 Mar;55(3):145–151. doi: 10.1016/0091-6749(75)90010-x. [DOI] [PubMed] [Google Scholar]
  33. Corkey R. F., Corkey B. E., Gimbrone M. A., Jr Hexose transport in normal and SV40-transformed human endothelial cells in culture. J Cell Physiol. 1981 Mar;106(3):425–434. doi: 10.1002/jcp.1041060312. [DOI] [PubMed] [Google Scholar]
  34. Crutchley D. J., Ryan U. S., Ryan J. W. Glucocorticoid modulation of prostacyclin production in cultured bovine pulmonary endothelial cells. J Pharmacol Exp Ther. 1985 Jun;233(3):650–655. [PubMed] [Google Scholar]
  35. Cuatrecasas P. Insulin--receptor interactions in adipose tissue cells: direct measurement and properties. Proc Natl Acad Sci U S A. 1971 Jun;68(6):1264–1268. doi: 10.1073/pnas.68.6.1264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Cury Y., Garcia-Leme J. The inflammatory response of hyperthyroid and hypothyroid rats. Role of adrenocortical steroids. Agents Actions. 1984 Oct;15(3-4):377–385. doi: 10.1007/BF01972375. [DOI] [PubMed] [Google Scholar]
  37. Davidson F. F., Dennis E. A. Biological relevance of lipocortins and related proteins as inhibitors of phospholipase A2. Biochem Pharmacol. 1989 Nov 1;38(21):3645–3651. doi: 10.1016/0006-2952(89)90567-4. [DOI] [PubMed] [Google Scholar]
  38. Dinarello C. A., Mier J. W. Lymphokines. N Engl J Med. 1987 Oct 8;317(15):940–945. doi: 10.1056/NEJM198710083171506. [DOI] [PubMed] [Google Scholar]
  39. Dolkart R. E., Halpern B., Perlman J. Comparison of antibody responses in normal and alloxan diabetic mice. Diabetes. 1971 Mar;20(3):162–167. doi: 10.2337/diab.20.3.162. [DOI] [PubMed] [Google Scholar]
  40. Drachman R. H., Root R. K., Wood W. B., Jr Studies on the effect of experimental nonketotic diabetes mellitus on antibacterial defense. I. Demonstration of a defect in phagocytosis. J Exp Med. 1966 Aug 1;124(2):227–240. doi: 10.1084/jem.124.2.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. EDLUND T., LOFGREN B., VALI L. Toxicity of dextran in rats. Nature. 1952 Jul 19;170(4316):125–125. doi: 10.1038/170125a0. [DOI] [PubMed] [Google Scholar]
  42. Erlansson M., Svensjö E., Bergqvist D. Leukotriene B4-induced permeability increase in postcapillary venules and its inhibition by three different antiinflammatory drugs. Inflammation. 1989 Dec;13(6):693–705. doi: 10.1007/BF00914313. [DOI] [PubMed] [Google Scholar]
  43. Esmann V. The diabetic leukocyte. Enzyme. 1972;13(1):32–55. [PubMed] [Google Scholar]
  44. Fairchild R. S., Kyner J. L., Abdou N. I. Specific immunoregulation abnormality in insulin-dependent diabetes mellitus. J Lab Clin Med. 1982 Feb;99(2):175–186. [PubMed] [Google Scholar]
  45. Fauci A. S., Dale D. C. The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. J Clin Invest. 1974 Jan;53(1):240–246. doi: 10.1172/JCI107544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Flower R. J. Background and discovery of lipocortins. Agents Actions. 1986 Jan;17(3-4):255–262. doi: 10.1007/BF01982616. [DOI] [PubMed] [Google Scholar]
  47. Fortes Z. B., Farsky S. P., Oliveira M. A., Garcia-Leme J. Direct vital microscopic study of defective leukocyte-endothelial interaction in diabetes mellitus. Diabetes. 1991 Oct;40(10):1267–1273. doi: 10.2337/diab.40.10.1267. [DOI] [PubMed] [Google Scholar]
  48. Fortes Z. B., Garcia Leme J., Scivoletto R. Influence of diabetes on the reactivity of mesenteric microvessels to histamine, bradykinin and acetylcholine. Br J Pharmacol. 1983 Jan;78(1):39–48. doi: 10.1111/j.1476-5381.1983.tb09360.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Fortes Z. B., Garcia Leme J., Scivoletto R. Vascular reactivity in diabetes mellitus: possible role of insulin on the endothelial cell. Br J Pharmacol. 1984 Nov;83(3):635–643. doi: 10.1111/j.1476-5381.1984.tb16217.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Fortes Z. B., Garcia Leme J., Scivoletto R. Vascular reactivity in diabetes mellitus: role of the endothelial cell. Br J Pharmacol. 1983 Jul;79(3):771–781. doi: 10.1111/j.1476-5381.1983.tb10016.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Fortes Z. B., Scivoletto R., Garcia-Leme J. Functional changes in the microcirculation of alloxan-induced diabetic rats. Gen Pharmacol. 1989;20(5):615–620. doi: 10.1016/0306-3623(89)90096-7. [DOI] [PubMed] [Google Scholar]
  52. Freychet P., Roth J., Neville D. M., Jr Insulin receptors in the liver: specific binding of ( 125 I)insulin to the plasma membrane and its relation to insulin bioactivity. Proc Natl Acad Sci U S A. 1971 Aug;68(8):1833–1837. doi: 10.1073/pnas.68.8.1833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Fussganger R. D., Kahn C. R., Roth J., De Meyts P. Binding and degradation of insulin by human peripheral granulocytes. Demonstration of specific receptors with high affinity. J Biol Chem. 1976 May 10;251(9):2761–2769. [PubMed] [Google Scholar]
  54. GLENN E. M., MILLER W. L., SCHLAGEL C. A. METABOLIC EFFECTS OF ADRENOCORTICAL STEROIDS IN VIVO AND IN VITRO: RELATIONSHIP TO ANTI-INFLAMMATORY EFFECTS. Recent Prog Horm Res. 1963;19:107–199. [PubMed] [Google Scholar]
  55. Gamble J. R., Harlan J. M., Klebanoff S. J., Vadas M. A. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci U S A. 1985 Dec;82(24):8667–8671. doi: 10.1073/pnas.82.24.8667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Garcia Leme J., Morato M., Souza M. Z. Anti-inflammatory action of glucagon in rats. Br J Pharmacol. 1975 Sep;55(1):65–68. doi: 10.1111/j.1476-5381.1975.tb07611.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Garcia-Leme J., Böhm G. M., Migliorini R. H., de Souza M. Z. Possible participation of insulin in the control of vascular permeability. Eur J Pharmacol. 1974 Dec;29(2):298–306. doi: 10.1016/0014-2999(74)90030-2. [DOI] [PubMed] [Google Scholar]
  58. Garcia-Leme J., Fortes Z. B., Sannomiya P., Farsky S. P. Insulin, glucocorticoids and the control of inflammatory responses. Agents Actions Suppl. 1992;36:99–118. [PubMed] [Google Scholar]
  59. Gaunt R., Gisoldi E., Smith N., Steinetz B. G., Chart J. J. Effect of thyroidectomy and aminoglutethimide on adrenal function in rats. Endocrinology. 1970 Nov;87(5):1088–1090. doi: 10.1210/endo-87-5-1088. [DOI] [PubMed] [Google Scholar]
  60. Gavin J. R., 3rd, Buell D. N., Roth J. Water-soluble insulin receptors from human lymphocytes. Science. 1972 Oct 13;178(4057):168–169. doi: 10.1126/science.178.4057.168. [DOI] [PubMed] [Google Scholar]
  61. Gavin J. R., 3rd, Roth J., Jen P., Freychet P. Insulin receptors in human circulating cells and fibroblasts. Proc Natl Acad Sci U S A. 1972 Mar;69(3):747–751. doi: 10.1073/pnas.69.3.747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Gillis S., Crabtree G. R., Smith K. A. Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation. J Immunol. 1979 Oct;123(4):1624–1631. [PubMed] [Google Scholar]
  63. Goulding N. J., Guyre P. M. Regulation of inflammation by lipocortin 1. Immunol Today. 1992 Aug;13(8):295–297. doi: 10.1016/0167-5699(92)90040-E. [DOI] [PubMed] [Google Scholar]
  64. Grunberger G., Robert A., Carpentier J. L., Dayer J. M., Roth A., Stevenson H. C., Orci L., Gorden P. Human circulating monocytes internalize 125I-insulin in a similar fashion to rat hepatocytes: relevance to receptor regulation in target and nontarget tissues. J Lab Clin Med. 1985 Aug;106(2):211–217. [PubMed] [Google Scholar]
  65. Gupta S., Fikrig S. M., Khanna S., Orti E. Deficiency of suppressor T-cells in insulin-dependent diabetes mellitus: an analysis with monoclonal antibodies. Immunol Lett. 1982 May;4(5):289–294. doi: 10.1016/0165-2478(82)90054-2. [DOI] [PubMed] [Google Scholar]
  66. Gustafsson J. A., Carlstedt-Duke J., Poellinger L., Okret S., Wikström A. C., Brönnegård M., Gillner M., Dong Y., Fuxe K., Cintra A. Biochemistry, molecular biology, and physiology of the glucocorticoid receptor. Endocr Rev. 1987 May;8(2):185–234. doi: 10.1210/edrv-8-2-185. [DOI] [PubMed] [Google Scholar]
  67. Hajek A. S., Joist J. H., Baker R. K., Jarett L., Daughaday W. H. Demonstration and partial characterization of insulin receptors in human platelets. J Clin Invest. 1979 May;63(5):1060–1065. doi: 10.1172/JCI109375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Haskell J. F., Meezan E., Pillion D. J. Identification of the insulin receptor of cerebral microvessels. Am J Physiol. 1985 Jan;248(1 Pt 1):E115–E125. doi: 10.1152/ajpendo.1985.248.1.E115. [DOI] [PubMed] [Google Scholar]
  69. Hempel K. H., Fernandez L. A., Persellin R. H. Effect of pregnancy sera on isolated lysosomes. Nature. 1970 Mar 7;225(5236):955–956. doi: 10.1038/225955a0. [DOI] [PubMed] [Google Scholar]
  70. Häring H. U. The insulin receptor: signalling mechanism and contribution to the pathogenesis of insulin resistance. Diabetologia. 1991 Dec;34(12):848–861. doi: 10.1007/BF00400192. [DOI] [PubMed] [Google Scholar]
  71. Inagaki N., Miura T., Nagai H., Ono Y., Koda A. Inhibition of vascular permeability increase in mice. An additional anti-allergic mechanism of glucocorticoids. Int Arch Allergy Appl Immunol. 1988;87(3):254–259. doi: 10.1159/000234681. [DOI] [PubMed] [Google Scholar]
  72. Ishikawa H., Mori Y., Tsurufuji S. The characteristic feature of glucocorticoids after local application with reference to leucocyte migration and protein exudation. Eur J Pharmacol. 1969 Aug;7(2):201–205. doi: 10.1016/0014-2999(69)90011-9. [DOI] [PubMed] [Google Scholar]
  73. Ishioka T., Honda Y., Sagara A., Shimamoto T. The effects of oestrogens on bluing lesions by bradykinin and histamine. Acta Endocrinol (Copenh) 1969 Feb;60(2):177–183. doi: 10.1530/acta.0.0600177. [DOI] [PubMed] [Google Scholar]
  74. Joris I., Majno G., Ryan G. B. Endothelial contraction in vivo: a study of the rat mesentery. Virchows Arch B Cell Pathol. 1972;12(1):73–83. doi: 10.1007/BF02893987. [DOI] [PubMed] [Google Scholar]
  75. Klebanoff S. J. Effect of estrogens on the myeloperoxidase-mediated antimicrobial system. Infect Immun. 1979 Jul;25(1):153–156. doi: 10.1128/iai.25.1.153-156.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Kono T., Barham F. W. The relationship between the insulin-binding capacity of fat cells and the cellular response to insulin. Studies with intact and trypsin-treated fat cells. J Biol Chem. 1971 Oct 25;246(20):6210–6216. [PubMed] [Google Scholar]
  77. Kontras S. B., Bodenbender J. G. Studies of the inflammatory cycle in juvenile diabetes. Am J Dis Child. 1968 Aug;116(2):130–134. doi: 10.1001/archpedi.1968.02100020132003. [DOI] [PubMed] [Google Scholar]
  78. Krug U., Krug F., Cuatrecasas P. Emergence of insulin receptors on human lymphocytes during in vitro transformation. Proc Natl Acad Sci U S A. 1972 Sep;69(9):2604–2608. doi: 10.1073/pnas.69.9.2604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Larkin J. G., Frier B. M., Ireland J. T. Diabetes mellitus and infection. Postgrad Med J. 1985 Mar;61(713):233–237. doi: 10.1136/pgmj.61.713.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Laue L., Kawai S., Brandon D. D., Brightwell D., Barnes K., Knazek R. A., Loriaux D. L., Chrousos G. P. Receptor-mediated effects of glucocorticoids on inflammation: enhancement of the inflammatory response with a glucocorticoid antagonist. J Steroid Biochem. 1988 Jun;29(6):591–598. doi: 10.1016/0022-4731(88)90156-2. [DOI] [PubMed] [Google Scholar]
  81. Leme J. G. Regulatory mechanisms in inflammation: new aspects of autopharmacology. Gen Pharmacol. 1981;12(1):15–24. doi: 10.1016/0306-3623(81)90022-7. [DOI] [PubMed] [Google Scholar]
  82. Leme J. G., Schapoval E. E. Stimulation of the hypothalamo-pituitary-adrenal axis by compounds formed in inflamed tissue. Br J Pharmacol. 1975 Jan;53(1):75–83. doi: 10.1111/j.1476-5381.1975.tb07332.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Lew W., Oppenheim J. J., Matsushima K. Analysis of the suppression of IL-1 alpha and IL-1 beta production in human peripheral blood mononuclear adherent cells by a glucocorticoid hormone. J Immunol. 1988 Mar 15;140(6):1895–1902. [PubMed] [Google Scholar]
  84. Litwack G. The glucocorticoid receptor at the protein level. Cancer Res. 1988 May 15;48(10):2636–2640. [PubMed] [Google Scholar]
  85. Livingston J. N., Saran B. R., Rose C. D., Anderson C. L. Rapid effects of insulin on the cycling of the insulin receptor in a human monocyte cell line (U-937). Diabetes. 1985 Apr;34(4):403–408. doi: 10.2337/diab.34.4.403. [DOI] [PubMed] [Google Scholar]
  86. Llorach M. A., Böhm G. M., Leme J. G. Decreased vascular reactions to permeability factors in experimental diabetes. Br J Exp Pathol. 1976 Dec;57(6):747–754. [PMC free article] [PubMed] [Google Scholar]
  87. Lo S. K., Detmers P. A., Levin S. M., Wright S. D. Transient adhesion of neutrophils to endothelium. J Exp Med. 1989 May 1;169(5):1779–1793. doi: 10.1084/jem.169.5.1779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Longhurst P. A., Head R. J. Responses of the isolated perfused mesenteric vasculature from diabetic rats: the significance of appropriate control tissues. J Pharmacol Exp Ther. 1985 Oct;235(1):45–49. [PubMed] [Google Scholar]
  89. Lopez A. F., Williamson D. J., Gamble J. R., Begley C. G., Harlan J. M., Klebanoff S. J., Waltersdorph A., Wong G., Clark S. C., Vadas M. A. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest. 1986 Nov;78(5):1220–1228. doi: 10.1172/JCI112705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. MAJNO G., PALADE G. E. Studies on inflammation. 1. The effect of histamine and serotonin on vascular permeability: an electron microscopic study. J Biophys Biochem Cytol. 1961 Dec;11:571–605. doi: 10.1083/jcb.11.3.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. MILES A. A., MILES E. M., BURKE J. The value and duration of defence reactions of the skin to the primary lodgement of bacteria. Br J Exp Pathol. 1957 Feb;38(1):79–96. [PMC free article] [PubMed] [Google Scholar]
  92. MILES A. A., NIVEN J. S. F. The enhancement of infection during shock produced by bacterial toxins and other agents. Br J Exp Pathol. 1950 Feb;31(1):73–95. [PMC free article] [PubMed] [Google Scholar]
  93. MUELLER M. N., KAPPAS A. ESTROGEN PHARMACOLOGY. II. SUPPRESSION OF EXPERIMENTAL IMMUNE POLYARTHRITIS. Proc Soc Exp Biol Med. 1964 Dec;117:845–847. doi: 10.3181/00379727-117-29715. [DOI] [PubMed] [Google Scholar]
  94. MacCuish A. C., Jordan J., Campbell C. J., Duncan L. J., Irvine W. J. Cell-mediated immunity in diabetes mellitus; lymphocyte transformation by insulin and insulin fragments in insulin-treated and newly-diagnosed diabetes. Diabetes. 1975 Jan;24(1):36–43. doi: 10.2337/diab.24.1.36. [DOI] [PubMed] [Google Scholar]
  95. MacLeod K. M. The effect of insulin treatment on changes in vascular reactivity in chronic, experimental diabetes. Diabetes. 1985 Nov;34(11):1160–1167. doi: 10.2337/diab.34.11.1160. [DOI] [PubMed] [Google Scholar]
  96. Maca R. D., Fry G. L., Hoak J. C. The effects of glucocorticoids on cultured human endothelial cells. Br J Haematol. 1978 Apr;38(4):501–509. doi: 10.1111/j.1365-2141.1978.tb01075.x. [DOI] [PubMed] [Google Scholar]
  97. Majno G., Gilmore V., Leventhal M. On the mechanism of vascular leakage caused by histaminetype mediators. A microscopic study in vivo. Circ Res. 1967 Dec;21(6):833–847. doi: 10.1161/01.res.21.6.833. [DOI] [PubMed] [Google Scholar]
  98. Majno G., Shea S. M., Leventhal M. Endothelial contraction induced by histamine-type mediators: an electron microscopic study. J Cell Biol. 1969 Sep;42(3):647–672. doi: 10.1083/jcb.42.3.647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Malaisse W. J., Malaisse-Lagae F., McCraw E. F. Effects of thyroid function upon insulin secretion. Diabetes. 1967 Sep;16(9):643–646. doi: 10.2337/diab.16.9.643. [DOI] [PubMed] [Google Scholar]
  100. Mengoli C., Montesi G., Lechi A., Ros A., Bellotti G., Scuro L. A. Influence of thyroid hormone on cortisol biosynthesis. A gaschromatographic analysis. J Steroid Biochem. 1980 Apr;13(4):445–447. doi: 10.1016/0022-4731(80)90352-0. [DOI] [PubMed] [Google Scholar]
  101. Miller M. E., Baker L. Leukocyte functions in juvenile diabetes mellitus: humoral and cellular aspects. J Pediatr. 1972 Nov;81(5):979–982. doi: 10.1016/s0022-3476(72)80555-9. [DOI] [PubMed] [Google Scholar]
  102. Moore N. A., Boler R. K. A comparative morphometric analysis of the effects of thyroxine and ACTH on the zona fasciculata of rat adrenal cortex. Am J Anat. 1976 Apr;145(4):517–523. doi: 10.1002/aja.1001450409. [DOI] [PubMed] [Google Scholar]
  103. Moraes F. R., Garcia Leme J. Endogenous corticosteroids and insulin in acute inflammation. Microvasc Res. 1982 May;23(3):281–293. doi: 10.1016/s0026-2862(82)80001-0. [DOI] [PubMed] [Google Scholar]
  104. Morel N. M., Petruzzo P. P., Hechtman H. B., Shepro D. Inflammatory agonists that increase microvascular permeability in vivo stimulate cultured pulmonary microvessel endothelial cell contraction. Inflammation. 1990 Oct;14(5):571–583. doi: 10.1007/BF00914277. [DOI] [PubMed] [Google Scholar]
  105. Moser R., Schleiffenbaum B., Groscurth P., Fehr J. Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. J Clin Invest. 1989 Feb;83(2):444–455. doi: 10.1172/JCI113903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Mowat A., Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med. 1971 Mar 25;284(12):621–627. doi: 10.1056/NEJM197103252841201. [DOI] [PubMed] [Google Scholar]
  107. Olefsky J. M. Decreased insulin binding to adipocytes and circulating monocytes from obese subjects. J Clin Invest. 1976 May;57(5):1165–1172. doi: 10.1172/JCI108384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Olefsky J. M. Effect of dexamethasone on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes. J Clin Invest. 1975 Dec;56(6):1499–1508. doi: 10.1172/JCI108231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Olefsky J. M. The insulin receptor: its role in insulin resistance of obesity and diabetes. Diabetes. 1976 Dec;25(12):1154–1162. doi: 10.2337/diab.25.12.1154. [DOI] [PubMed] [Google Scholar]
  110. Olefsky J., Reaven G. M. The human lymphocyte: a model for the study of insulin-receptor interaction. J Clin Endocrinol Metab. 1974 Apr;38(4):554–560. doi: 10.1210/jcem-38-4-554. [DOI] [PubMed] [Google Scholar]
  111. PERILLIE P. E., NOLAN J. P., FINCH S. C. Studies of the resistance to infection in diabetes mellitus: local exudative cellular response. J Lab Clin Med. 1962 Jun;59:1008–1015. [PubMed] [Google Scholar]
  112. Parrillo J. E., Fauci A. S. Mechanisms of glucocorticoid action on immune processes. Annu Rev Pharmacol Toxicol. 1979;19:179–201. doi: 10.1146/annurev.pa.19.040179.001143. [DOI] [PubMed] [Google Scholar]
  113. Peers S. H., Moon D., Flower R. J. Reversal of the anti-inflammatory effects of dexamethasone by the glucocorticoid antagonist RU 38486. Biochem Pharmacol. 1988 Feb 1;37(3):556–557. doi: 10.1016/0006-2952(88)90230-4. [DOI] [PubMed] [Google Scholar]
  114. Pereira M. A., Sannomiya P., Leme J. G. Inhibition of leukocyte chemotaxis by factor in alloxan-induced diabetic rat plasma. Diabetes. 1987 Nov;36(11):1307–1314. doi: 10.2337/diab.36.11.1307. [DOI] [PubMed] [Google Scholar]
  115. Perper R. J., Sanda M., Chinea G., Oronsky A. L. Leukocyte chemotaxis in vivo. II. Analysis of the selective inhibition of neutrophil or mononuclear cell accumulation. J Lab Clin Med. 1974 Sep;84(3):394–406. [PubMed] [Google Scholar]
  116. Pessin J. E., Gitomer W., Oka Y., Oppenheimer C. L., Czech M. P. beta-Adrenergic regulation of insulin and epidermal growth factor receptors in rat adipocytes. J Biol Chem. 1983 Jun 25;258(12):7386–7394. [PubMed] [Google Scholar]
  117. Pfaffman M. A., Ball C. R., Darby A., Hilman R. Insulin reversal of diabetes-induced inhibition of vascular contractility in the rat. Am J Physiol. 1982 Apr;242(4):H490–H495. doi: 10.1152/ajpheart.1982.242.4.H490. [DOI] [PubMed] [Google Scholar]
  118. Pillion D. J., Haskell J. F., Meezan E. Cerebral cortical microvessels: an insulin-sensitive tissue. Biochem Biophys Res Commun. 1982 Jan 29;104(2):686–692. doi: 10.1016/0006-291x(82)90691-x. [DOI] [PubMed] [Google Scholar]
  119. Pozzilli P., Zuccarini O., Iavicoli M., Andreani D., Sensi M., Spencer K. M., Bottazzo G. F., Beverley P. C., Kyner J. L., Cudworth A. G. Monoclonal antibodies defined abnormalities of T-lymphocytes in type I (insulin-dependent) diabetes. Diabetes. 1983 Jan;32(1):91–94. doi: 10.2337/diab.32.1.91. [DOI] [PubMed] [Google Scholar]
  120. Rayfield E. J., Curnow R. T., George D. T., Beisel W. R. Impaired carbohydrate metabolism during a mild viral illness. N Engl J Med. 1973 Sep 20;289(12):618–621. doi: 10.1056/NEJM197309202891207. [DOI] [PubMed] [Google Scholar]
  121. STEINETZ B. G., BEACH V. L. Some influences of thyroid on the pituitary-adrenal axis. Endocrinology. 1963 Jan;72:45–58. doi: 10.1210/endo-72-1-45. [DOI] [PubMed] [Google Scholar]
  122. Sannomiya P., Pereira M. A., Garcia-Leme J. Inhibition of leukocyte chemotaxis by serum factor in diabetes mellitus: selective depression of cell responses mediated by complement-derived chemoattractants. Agents Actions. 1990 Jun;30(3-4):369–376. doi: 10.1007/BF01966301. [DOI] [PubMed] [Google Scholar]
  123. Sapolsky R., Rivier C., Yamamoto G., Plotsky P., Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science. 1987 Oct 23;238(4826):522–524. doi: 10.1126/science.2821621. [DOI] [PubMed] [Google Scholar]
  124. Savin J. A. Bacterial infections in diabetes mellitus. Br J Dermatol. 1974 Oct;91(4):481–484. doi: 10.1111/j.1365-2133.1974.tb13096.x. [DOI] [PubMed] [Google Scholar]
  125. Schleimer R. P., Freeland H. S., Peters S. P., Brown K. E., Derse C. P. An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils. J Pharmacol Exp Ther. 1989 Aug;250(2):598–605. [PubMed] [Google Scholar]
  126. Sherman M. R., Stevens J. Structure of mammalian steroid receptors: evolving concepts and methodological developments. Annu Rev Physiol. 1984;46:83–105. doi: 10.1146/annurev.ph.46.030184.000503. [DOI] [PubMed] [Google Scholar]
  127. Snyder D. S., Unanue E. R. Corticosteroids inhibit murine macrophage Ia expression and interleukin 1 production. J Immunol. 1982 Nov;129(5):1803–1805. [PubMed] [Google Scholar]
  128. Spangler A. S., Antoniades H. N., Sotman S. L., Inderbitizin T. M. Enhancement of the anti-inflammatory action of hydrocortisone by estrogen. J Clin Endocrinol Metab. 1969 May;29(5):650–655. doi: 10.1210/jcem-29-5-650. [DOI] [PubMed] [Google Scholar]
  129. Staruch M. J., Wood D. D. Reduction of serum Interleukin-1-like activity after treatment with dexamethasone. J Leukoc Biol. 1985 Feb;37(2):193–207. doi: 10.1002/jlb.37.2.193. [DOI] [PubMed] [Google Scholar]
  130. Stenberg V. I., Bouley M. G., Katz B. M., Lee K. J., Parmar S. S. Negative endocrine control system for inflammation in rats. Agents Actions. 1990 Mar;29(3-4):189–195. doi: 10.1007/BF01966446. [DOI] [PubMed] [Google Scholar]
  131. Sternberg E. M., Hill J. M., Chrousos G. P., Kamilaris T., Listwak S. J., Gold P. W., Wilder R. L. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2374–2378. doi: 10.1073/pnas.86.7.2374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. TIMIRAS P. S., WOODBURY D. M. Adrenocortical function after administration of thyroxine and triiodothyronine in rats. J Pharmacol Exp Ther. 1955 Oct;115(2):144–153. [PubMed] [Google Scholar]
  133. Tan J. S., Anderson J. L., Watanakunakorn C., Phair J. P. Neutrophil dysfunction in diabetes mellitus. J Lab Clin Med. 1975 Jan;85(1):26–33. [PubMed] [Google Scholar]
  134. Tonnesen M. G., Smedly L. A., Henson P. M. Neutrophil-endothelial cell interactions. Modulation of neutrophil adhesiveness induced by complement fragments C5a and C5a des arg and formyl-methionyl-leucyl-phenylalanine in vitro. J Clin Invest. 1984 Nov;74(5):1581–1592. doi: 10.1172/JCI111574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Tsurufuji S., Sugio K., Takemasa F. The role of glucocorticoid receptor and gene expression in the anti-inflammatory action of dexamethasone. Nature. 1979 Aug 2;280(5721):408–410. doi: 10.1038/280408a0. [DOI] [PubMed] [Google Scholar]
  136. Vincent J. E., Bonta I. L., de Vries-Kragt K., Bhargava N. L'influence des oestrogènes sur la perméabilité de la paroi vasculaire. Steroidologia. 1971;1(6):367–377. [PubMed] [Google Scholar]
  137. Vishwanath B. S., Frey F. J., Bradbury M., Dallman M. F., Frey B. M. Adrenalectomy decreases lipocortin-I messenger ribonucleic acid and tissue protein content in rats. Endocrinology. 1992 Feb;130(2):585–591. doi: 10.1210/endo.130.2.1531128. [DOI] [PubMed] [Google Scholar]
  138. WALLACH D. P., REINEKE E. P. The effect of varying levels of thyroidal stimulation on the ascorbic acid content of the adrenal cortex. Endocrinology. 1949 Jul;45(1):75–81. doi: 10.1210/endo-45-1-75. [DOI] [PubMed] [Google Scholar]
  139. WERTMAN K. F., HENNEY M. R. The effects of alloxan diabetes on phagocytosis and susceptibility to infection. J Immunol. 1962 Sep;89:314–317. [PubMed] [Google Scholar]
  140. Whitehouse B. J. Lipocortins, mediators of the anti-inflammatory actions of corticosteroids? J Endocrinol. 1989 Dec;123(3):363–366. doi: 10.1677/joe.0.1230363. [DOI] [PubMed] [Google Scholar]
  141. Yamamoto K. R. Steroid receptor regulated transcription of specific genes and gene networks. Annu Rev Genet. 1985;19:209–252. doi: 10.1146/annurev.ge.19.120185.001233. [DOI] [PubMed] [Google Scholar]
  142. ZARROW M. X., HORGER L. M., MCCARTHY J. L. Atrophy of adrenal gland following thiouracil and vitamin B12. Proc Soc Exp Biol Med. 1957 Feb;94(2):348–349. doi: 10.3181/00379727-94-22940. [DOI] [PubMed] [Google Scholar]
  143. Zier K. S., Leo M. M., Spielman R. S., Baker L. Decreased synthesis of interleukin-2 (IL-2) in insulin-dependent diabetes mellitus. Diabetes. 1984 Jun;33(6):552–555. doi: 10.2337/diab.33.6.552. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES